A detailed history of Jcic Asset Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Jcic Asset Management Inc. holds 4,216 shares of LLY stock, worth $3.24 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
4,216
Previous 4,174 1.01%
Holding current value
$3.24 Million
Previous $3.78 Million 1.16%
% of portfolio
1.66%
Previous 1.66%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $32,429 - $40,320
42 Added 1.01%
4,216 $3.74 Million
Q2 2024

Jul 10, 2024

SELL
$724.87 - $909.04 $15,222 - $19,089
-21 Reduced 0.5%
4,174 $3.78 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $2.46 Million - $3.3 Million
4,160 Added 11885.71%
4,195 $3.26 Million
Q4 2023

Jan 16, 2024

SELL
$525.19 - $619.13 $7,877 - $9,286
-15 Reduced 30.0%
35 $20,000
Q3 2023

Oct 11, 2023

SELL
$434.7 - $599.3 $4,347 - $5,993
-10 Reduced 16.67%
50 $26,000
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $1,753 - $2,344
-5 Reduced 7.69%
60 $28,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $29,648 - $33,787
-100 Reduced 60.61%
65 $24,000
Q2 2022

Jun 07, 2022

SELL
$278.73 - $327.27 $4,180 - $4,909
-15 Reduced 8.33%
165 $53,000
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $14,615 - $18,137
65 Added 56.52%
180 $50,000
Q1 2021

Apr 14, 2021

BUY
$164.32 - $212.72 $18,896 - $24,462
115 New
115 $21,000
Q3 2019

Oct 07, 2019

SELL
$106.79 - $116.16 $3.75 Million - $4.08 Million
-35,111 Closed
0 $0
Q2 2019

Jul 15, 2019

SELL
$110.79 - $129.32 $21,604 - $25,217
-195 Reduced 0.55%
35,111 $3.89 Million
Q1 2019

Apr 12, 2019

BUY
$111.31 - $131.02 $3.93 Million - $4.63 Million
35,306 New
35,306 $4.58 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jcic Asset Management Inc. Portfolio

Follow Jcic Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jcic Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jcic Asset Management Inc. with notifications on news.